ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Illumina Gives Upbeat View For 1Q

DOW JONES NEWSWIRES Illumina Inc. (ILMN) projected its first-quarter earnings will at least meet Wall Street estimates and forecast revenue above expectations. The upbeat guidance follows Swiss drug maker Roche Holding AG's (ROG.VX, RHHBY) sweetened takeover bid last week for Illumina, which makes machines that use blood or tissue samples to decode a person's entire genetic make-up in about a week--a process known as DNA sequencing. Illumina expects per-share earnings will meet or exceed analysts estimates on revenue of about $270 million. Analysts polled by Thomson Reuters recently expected 31 cents a share and $257 million, respectively. Roche on Thursday raised its offer to $51 a share in an effort to reach a friendly deal after some of the U.S. gene-sequencing company's shareholders signaled that they wanted to accelerate the takeover process. Roche wants to buy Illumina to expand its offering of personalized medicines, a growing health-care field in which some of the largest pharmaceutical companies are vying to tailor treatments to patients' unique make-ups by using diagnostic tests. In February, Illumina's board unanimously rejected an earlier bid, calling the Swiss company's offer inadequate. Illumina in February also reported its fourth-quarter earnings dropped 70% as one-time charges masked a stronger core profit. The company expects to report first-quarter results later this month. Roche's American depositary shares were inactive in recent premarket trading. Illumina shares were down 1.4% at $51.85 in recent premarket trading. The company's shares have surged nearly 73% this year amid the takeover bid. -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stock News for Illumina (ILMN)
DateTimeHeadline
03/19/201519:53:52Statement of Changes in Beneficial Ownership (4)
03/18/201508:31:00Matthew Posard Joins Trovagene's Executive Management Team as...
03/16/201518:47:33Statement of Changes in Beneficial Ownership (4)
03/16/201518:22:42Statement of Changes in Beneficial Ownership (4)
03/16/201504:05:00Illumina Files Patent Infringement Suit in the United Kingdom...
03/13/201519:37:42Statement of Changes in Beneficial Ownership (4)
03/12/201517:56:41Statement of Changes in Beneficial Ownership (4)
03/11/201519:48:34Statement of Changes in Beneficial Ownership (4)
03/11/201519:48:34Statement of Changes in Beneficial Ownership (4)
03/11/201519:48:12Statement of Changes in Beneficial Ownership (4)
03/11/201519:47:43Statement of Changes in Beneficial Ownership (4)
03/11/201519:47:43Statement of Changes in Beneficial Ownership (4)
03/11/201519:47:21Statement of Changes in Beneficial Ownership (4)
03/10/201509:00:00Illumina Announces Strategic Collaboration with Merck Serono...
03/09/201503:59:30Looking Back At 2014 And What To Expect In 2015 For Sequenom
03/04/201506:30:00Illumina Launches TruSight HLA Solution
02/26/201506:30:00Illumina Accelerator Secures $40 Million Boost Capital to Back...
02/23/201506:30:00Illumina Launches the NeoPrep Library Prep System
02/18/201506:30:00Illumina to Webcast Live Presentation at the Cowen and Company...
02/13/201513:58:58Amended Statement of Ownership (sc 13g/a)

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad